Campbell & CO Investment Adviser LLC Exact Sciences Corp Transaction History

Campbell & CO Investment Adviser LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$59.06 - $75.72 $1.17 Million - $1.5 Million	-19,797 Reduced 73.28%	7,219 $534,000
Q3 2023 Nov 08, 2023	BUY	$65.94 - $99.04 $1.57 Million - $2.36 Million	23,808 Added 742.14%	27,016 $1.84 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $201,077 - $304,920	3,208 New	3,208 $301,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $76,248 - $117,747	2,385 Added 25.97%	11,567 $376,000
Q2 2022 Aug 09, 2022	BUY	$35.61 - $76.23 $326,971 - $699,943	9,182 New	9,182 $362,000
Q4 2021 Feb 10, 2022	SELL	$72.5 - $100.68 $177,987 - $247,169	-2,455 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $49,632 - $68,227	-550 Reduced 18.3%	2,455 $234,000
Q2 2021 Aug 11, 2021	BUY	$93.66 - $139.27 $281,448 - $418,506	3,005 New	3,005 $374,000
Q4 2019 Jan 23, 2020	SELL	$77.66 - $99.74 $306,989 - $394,272	-3,953 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$90.37 - $122.49 $357,232 - $484,202	3,953 New	3,953 $357,000

661

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.78B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.